[1]
|
Mathers, C.D. and Loncar, D. (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLoS Medicine, 3, Article No. e442. https://doi.org/10.1371/journal.pmed.0030442
|
[2]
|
Stokes, A. and Preston, S.H. (2017) Deaths Attributable to Diabetes in the United States: Comparison of Data Sources and Estimation Approaches. PLoS ONE, 12, Article ID: e0170219. https://doi.org/10.1371/journal.pone.0170219
|
[3]
|
Flannick, J. and Florez, J.C. (2016) Type 2 Diabetes: Genetic Data Sharing to Advance Complex Disease Research. Nature Reviews Genetics, 17, 535-549. https://doi.org/10.1038/nrg.2016.56
|
[4]
|
Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler, P.C. (2003) Beta-Cell Deficit and Increased Beta-Cell Apoptosis in Humans with Type 2 Diabetes. Diabetes, 52, 102-110.
https://doi.org/10.2337/diabetes.52.1.102
|
[5]
|
Rahier, J., Guiot, Y., Goebbels, R.M., Sempoux, C. and Henquin, J.C. (2008) Pancreatic Beta-Cell Mass in European Subjects with Type 2 Diabetes. Diabetes, Obesity and Metabolism, 10, 32-42.
https://doi.org/10.1111/j.1463-1326.2008.00969.x
|
[6]
|
Mitchell, J.D. (2021) Personalizing Risk Assess-ment in Diabetes Mellitus and Metabolic Syndrome. JACC: Cardiovascular Imaging, 14, 230-232. https://doi.org/10.1016/j.jcmg.2020.11.002
|
[7]
|
Forbes, J.M. and Cooper, M.E. (2013) Mechanisms of Diabetic Complications. Physiological Reviews, 93, 137-188.
https://doi.org/10.1152/physrev.00045.2011
|
[8]
|
Karter, A.J., Laiteerapong, N., Chin, M.H., Moffet, H.H., Parker, M.M., Sudore, R., Adams, A.S., Schillinger, D., Adler, N.S., Whitmer, R.A., Piette, J.D. and Huang, E.S. (2015) Ethnic Differences in Geriatric Conditions and Diabetes Complications among Older, Insured Adults with Diabetes: The Diabe-tes and Aging Study. Journal of Aging and Health, 27, 894-918. https://doi.org/10.1177/0898264315569455
|
[9]
|
Shapiro, A.M., Pokrywczynska, M. and Ricordi, C. (2017) Clin-ical Pancreatic Islet Transplantation. Nature Reviews Endocrinology, 13, 268-277. https://doi.org/10.1038/nrendo.2016.178
|
[10]
|
Vantyghem, M.C., de Koning, E.J.P., Pattou, F. and Rickels, M.R. (2019) Advances in β-Cell Replacement Therapy for the Treatment of Type 1 Diabetes. Lancet, 394, 1274-1285. https://doi.org/10.1016/S0140-6736(19)31334-0
|
[11]
|
Gruessner, R.W. and Gruessner, A.C. (2013) The Current State of Pancreas Transplantation. Nature Reviews Endocrinology, 9, 555-562. https://doi.org/10.1038/nrendo.2013.138
|
[12]
|
Lombardo, C., Perrone, V.G., Amorese, G., Vistoli, F., Baronti, W., Marchetti, P. and Boggi, U. (2017) Update on Pancreatic Transplantation on the Management of Diabetes. Minerva Medica, 108, 405-418.
https://doi.org/10.23736/S0026-4806.17.05224-7
|
[13]
|
Shapiro, A.M., Lakey, J.R., Ryan, E.A., Korbutt, G.S., Toth, E., Warnock, G.L., Kneteman, N.M. and Rajotte, R.V. (2000) Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen. New England Journal of Medicine, 343, 230-238.
https://doi.org/10.1056/NEJM200007273430401
|
[14]
|
Fournier, B., Andereggen, E., Bühler, L., Oberholzer, J., Mage, R., Sinigaglia, C., Mentha, G. and Morel, P. (1998) Evaluation à long-terme de 9 autotransplantations d'îlots de Langerhans après résection du pancréas (Long-term follow-up of 9 islets of Langerhans autografts after resection of the pancreas). Schweiz Med Wochenschr, 128, 856-859.
|
[15]
|
Dean, P.G., Kukla, A., Stegall, M.D. and Kudva, Y.C. (2017) Pancreas Transplantation. BMJ, 357, Article No. j1321.
https://doi.org/10.1136/bmj.j1321
|
[16]
|
Rickels, M.R. and Robertson, R.P. (2019) Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions. Endocrine Reviews, 40, 631-668. https://doi.org/10.1210/er.2018-00154
|
[17]
|
Calne, R. (2005) Cell Transplantation for Diabetes. Philosophical Transactions of the Royal Society B: Biological Sciences, 360, 1769-1774. https://doi.org/10.1098/rstb.2005.1707
|
[18]
|
Woodward, K.B., Zhao, H., Shrestha, P., Batra, L., Tan, M., Gri-many-Nuno, O., Bandura-Morgan, L., Askenasy, N., Shirwan, H. and Yolcu, E.S. (2020) Pancreatic Islets Engineered with a FasL Protein Induce Systemic Tolerance at the Induction Phase That Evolves into Long-Term Graft-Localized Immune Privilege. American Journal of Transplantation, 20, 1285-1295. https://doi.org/10.1111/ajt.15747
|
[19]
|
Al-Qaoud, T.M., Odorico, J.S. and Redfield 3rd., R.R. (2018) Pancreas Transplantation in Type 2 Diabetes: Expanding the Criteria. Current Opinion in Organ Transplantation, 23, 454-460.
https://doi.org/10.1097/MOT.0000000000000553
|
[20]
|
Pagliuca, F.W., Millman, J.R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J.H., Peterson, Q.P., Greiner, D. and Melton, D.A. (2014) Generation of Functional Human Pancreatic β Cells in Vitro. Cell, 159, 428-439.
https://doi.org/10.1016/j.cell.2014.09.040
|
[21]
|
Shahjalal, H.M., Abdal Dayem, A., Lim, K.M., Jeon, T.I. and Cho, S.G. (2018) Generation of Pancreatic β Cells for Treatment of Diabetes: Advances and Challenges. Stem Cell Research & Therapy, 9, Article No. 355.
https://doi.org/10.1186/s13287-018-1099-3
|
[22]
|
Päth, G., Perakakis, N., Mantzoros, C.S. and Seufert, J. (2019) Stem Cells in the Treatment of Diabetes Mellitus—Focus on Mesenchymal Stem Cells. Metabolism, 90, 1-15. https://doi.org/10.1016/j.metabol.2018.10.005
|
[23]
|
Balboa, D., Saarimäki-Vire, J. and Otonkoski, T. (2019) Con-cise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic β-Cell Pathology. Stem Cells, 37, 33-41. https://doi.org/10.1002/stem.2913
|
[24]
|
Blyszczuk, P., Asbrand, C., Rozzo, A., Kania, G., St-Onge, L., Rupnik, M. and Wobus, A.M. (2004) Embryonic Stem Cells Differentiate into Insulin-Producing Cells without Selection of Nes-tin-Expressing Cells. International Journal of Developmental Biology, 48, 1095-104. https://doi.org/10.1387/ijdb.041904pb
|
[25]
|
Lumelsky, N., Blondel, O., Laeng, P., Velasco, I., Ravin, R. and McKay, R. (2001) Differentiation of Embryonic Stem Cells to Insulin-Secreting Structures Similar to Pancreatic Islets. Science, 292, 1389-1394.
https://doi.org/10.1126/science.1058866
|
[26]
|
Solter, D. (2006) From Teratocarcinomas to Embryonic Stem Cells and Beyond: A History of Embryonic Stem Cell Research. Nature Reviews Genetics, 7, 319-327. https://doi.org/10.1038/nrg1827
|
[27]
|
Thomson, J.A., Kalishman, J., Golos, T.G., Durning, M., Harris, C.P., Becker, R.A. and Hearn, J.P. (1995) Isolation of a Primate Embryonic Stem Cell Line. Proceedings of the National Academy of Sciences of the United States of America, 92, 7844-7848. https://doi.org/10.1073/pnas.92.17.7844
|
[28]
|
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. and Jones, J.M. (1998) Embryonic Stem Cell Lines Derived from Human Blastocysts. Science, 282, 1145-1147.
https://doi.org/10.1126/science.282.5391.1145
|
[29]
|
D’Amour, K.A., Bang, A.G., Eliazer, S., Kelly, O.G., Agulnick, A.D., Smart, N.G., Moorman, M.A., Kroon, E., Carpenter, M.K. and Baetge, E.E. (2006) Production of Pan-creatic Hormone-Expressing Endocrine Cells from Human Embryonic Stem Cells. Nature Biotechnology, 24, 1392-1401. https://doi.org/10.1038/nbt1259
|
[30]
|
Baetge, E.E. (2008) Production of Beta-Cells from Human Embryonic Stem Cells. Diabetes, Obesity and Metabolism, 10, 186-194. https://doi.org/10.1111/j.1463-1326.2008.00956.x
|
[31]
|
Shim, J.H., Kim, S.E., Woo, D.H., Kim, S.K., Oh, C.H., McKay, R. and Kim, J.H. (2007) Directed Differentiation of Human Embryonic Stem Cells towards a Pancreatic Cell Fate. Diabetologia, 50, 1228-1238.
https://doi.org/10.1007/s00125-007-0634-z
|
[32]
|
Rezania, A., Bruin, J.E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O’Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., Yang, Y.H., Johnson, J.D. and Kieffer, T.J. (2014) Reversal of Diabetes with Insulin-Producing Cells Derived in Vitro from Human Pluripotent Stem Cells. Nature Bio-technology, 32, 1121-1133.
https://doi.org/10.1038/nbt.3033
|
[33]
|
Vegas, A.J., Veiseh, O., Gürtler, M., Millman, J.R., Pagliuca, F.W., Bader, A.R., Doloff, J.C., Li, J., Chen, M., Olejnik, K., Tam, H.H., Jhunjhunwala, S., Langan, E., Aresta-Dasilva, S., Gandham, S., McGarrigle, J.J., Bochenek, M.A., Hollister-Lock, J., Oberholzer, J., Greiner, D.L., Weir, G.C., Melton, D.A., Lang-er, R. and Anderson, D.G. (2016) Long-Term Glycemic Control Using Polymer-Encapsulated Human Stem Cell-Derived Beta Cells in Immune-Competent Mice. Nature Medicine, 22, 306-311. https://doi.org/10.1038/nm.4030
|
[34]
|
Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y. and Deng, H. (2009) Highly Efficient Differentiation of Human ES Cells and iPS Cells into Mature Pancreatic Insulin-Producing Cells. Cell Research, 19, 429-438.
https://doi.org/10.1038/cr.2009.28
|
[35]
|
Tuch, B.E. (1991) Reversal of Diabetes by Human Fetal Pancreas. Opti-mization of Requirements in the Hyperglycemic Nude Mouse. Transplantation, 51, 557-562. https://doi.org/10.1097/00007890-199103000-00002
|
[36]
|
Hayek, A. and Beattie, G.M. (1997) Experimental Transplantation of Human Fetal and Adult Pancreatic Islets. Journal of Clinical Endocrinology & Metabolism, 82, 2471-2475. https://doi.org/10.1210/jc.82.8.2471
|
[37]
|
Kroon, E., Martinson, L.A, Kadoya, K., Bang, A.G., Kelly, O.G., Eliazer, S., Young, H., Richardson, M., Smart, N.G., Cunningham, J., Agulnick, A.D., D’Amour, K.A, Carpenter, M.K. and Baetge, E.E. (2008) Pancreatic Endoderm Derived from Human Embryonic Stem Cells Generates Glu-cose-Responsive Insulin-Secreting Cells in Vivo. Nature Biotechnology, 26, 443-452. https://doi.org/10.1038/nbt1393
|
[38]
|
Veres, A., Faust, A.L., Bushnell, H.L., Engquist, E.N., Kenty, J.H., Harb, G., Poh, Y.C., Sintov, E., Gürtler, M., Pagliuca, F.W., Peterson, Q.P. and Melton, D.A. (2019) Charting Cellular Identity during Human in Vitro β-Cell Differentiation. Nature, 569, 368-373. https://doi.org/10.1038/s41586-019-1168-5
|
[39]
|
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell, 131, 861-872.
https://doi.org/10.1016/j.cell.2007.11.019
|
[40]
|
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I. and Thomson, J.A. (2007) Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science, 318, 1917-1920. https://doi.org/10.1126/science.1151526
|
[41]
|
Lanza, R. (2007) Stem Cell Breakthrough: Don’t Forget Ethics. Sci-ence, 318, 1865.
https://doi.org/10.1126/science.318.5858.1865a
|
[42]
|
Tateishi, K., He, J., Taranova, O., Liang, G., D’Alessio, A.C. and Zhang, Y. (2008) Generation of Insulin-Secreting Islet-Like Clusters from Human Skin Fibroblasts. Journal of Bio-logical Chemistry, 283, 31601-31607.
https://doi.org/10.1074/jbc.M806597200
|
[43]
|
Chen, S., Borowiak, M., Fox, J.L., Maehr, R., Osafune, K., Da-vidow, L., Lam, K., Peng, L.F., Schreiber, S.L., Rubin, L.L. and Melton, D. (2009) A Small Molecule That Directs Dif-ferentiation of Human ESCs into the Pancreatic Lineage. Nature Chemical Biology, 5, 258-265. https://doi.org/10.1038/nchembio.154
|
[44]
|
Yang, Y.P. and Wright, C. (2009) Chemicals Turn Human Embryonic Stem Cells towards Beta Cells. Nature Chemical Biology, 5, 195-196. https://doi.org/10.1038/nchembio0409-195
|
[45]
|
Bose, B., Shenoy, S.P., Konda, S. and Wangikar, P. (2012) Hu-man Embryonic Stem Cell Differentiation into Insulin Secreting β-Cells for Diabetes. Cell Biology International, 36, 1013-1020. https://doi.org/10.1042/CBI20120210
|
[46]
|
Stepniewski, J., Kachamakova-Trojanowska, N., Ogrocki, D., Szopa, M., Matlok, M., Beilharz, M., Dyduch, G., Malecki, M.T., Jozkowicz, A. and Dulak, J. (2015) Induced Plu-ripotent Stem Cells as a Model for Diabetes Investigation. Scientific Reports, 5, Article No. 8597. https://doi.org/10.1038/srep08597
|
[47]
|
Millman, J.R., Xie, C., Van Dervort, A., Gürtler, M., Pagliuca, F.W. and Melton, D.A. (2016) Generation of Stem Cell-Derived β-Cells from Patients with Type 1 Diabetes. Nature Communica-tions, 7, Article No. 11463.
https://doi.org/10.1038/ncomms11463
|
[48]
|
Manzar, G.S., Kim, E.M. and Zavazava, N. (2017) Demethylation of Induced Pluripotent Stem Cells from Type 1 Diabetic Patients Enhances Differentiation into Functional Pancreatic β Cells. Journal of Biological Chemistry, 292, 14066-14079. https://doi.org/10.1074/jbc.M117.784280
|
[49]
|
Rajaei, B., Shamsara, M., Amirabad, L.M., Massumi, M. and Sanati, M.H. (2017) Pancreatic Endoderm-Derived from Diabetic Pa-tient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells. Journal of Cellular Physiology, 232, 2616-2625. https://doi.org/10.1002/jcp.25459
|
[50]
|
Zhang, Y., Xu, J., Ren, Z., Meng, Y., Liu, W., Lu, L., Zhou, Z. and Chen, G. (2021) Nicotinamide Promotes Pancreatic Differentiation through the Dual Inhibition of CK1 and ROCK Kinases in Human Embryonic Stem Cells. Stem Cell Research & Therapy, 12, 362.
|
[51]
|
Ghazizadeh, Z., Kao, D.I., Amin, S., Cook, B., Rao, S., Zhou, T., Zhang, T., Xiang, Z., Kenyon, R., Kaymakcalan, O., Liu, C., Evans, T. and Chen, S. (2017) ROCKII Inhibition Promotes the Maturation of Human Pancreatic Beta-Like Cells. Nature Communications, 8, Article No. 298. https://doi.org/10.1038/s41467-017-00129-y
|
[52]
|
Nair, G.G., Liu, J.S., Russ, H.A., Tran, S., Saxton, M.S., Chen, R., Juang, C., Li, M.L., Nguyen, V.Q., Giacometti, S., Puri, S., Xing, Y., Wang, Y., Szot, G.L., Oberholzer, J., Bhushan, A. and Hebrok, M. (2019) Recapitulating Endocrine Cell Clustering in Culture Promotes Maturation of Human Stem-Cell-Derived β Cells. Nature Cell Biology, 21, 263-274.
https://doi.org/10.1038/s41556-018-0271-4
|
[53]
|
Velazco-Cruz, L., Song, J., Maxwell, K.G., Goedegebuure, M.M., Augsornworawat, P., Hogrebe, N.J. and Millman, J.R. (2019) Acquisition of Dynamic Function in Human Stem Cell-Derived β Cells. Stem Cell Reports, 12, 351-365.
https://doi.org/10.1016/j.stemcr.2018.12.012
|
[54]
|
Yoshihara, E., O’Connor, C., Gasser, E., Wei, Z., Oh, T.G., Tseng, T.W., Wang, D., Cayabyab, F., Dai, Y., Yu, R.T., Liddle, C., Atkins, A.R., Downes, M. and Evans, R.M. (2020) Immune-Evasive Human Islet-Like Organoids Ameliorate Diabetes. Nature, 586, 606-611. https://doi.org/10.1038/s41586-020-2631-z
|
[55]
|
Ben-Ami, E., Berrih-Aknin, S. and Miller, A. (2011) Mesenchy-mal Stem Cells as an Immunomodulatory Therapeutic Strategy for Autoimmune Diseases. Autoimmunity Reviews, 10, 410-415. https://doi.org/10.1016/j.autrev.2011.01.005
|
[56]
|
Chamberlain, G., Fox, J., Ashton, B. and Middleton, J. (2007) Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing. Stem Cells, 25, 2739-2749.
https://doi.org/10.1634/stemcells.2007-0197
|
[57]
|
Mohammadian, M., Shamsasenjan, K., Lotfi Nezhad, P., Talebi, M., Jahedi, M., Nickkhah, H., Minayi, N. and Movassaghpour, A. (2013) Mesenchymal Stem Cells: New Aspect in Cell-Based Regenerative Therapy. Advanced Pharmaceutical Bulletin, 3, 433-437. https://doi.org/10.5681/apb.2013.070
|
[58]
|
Vasanthan, J., Gurusamy, N., Rajasingh, S., Sigamani, V., Kirankumar, S., Thomas, E.L. and Rajasingh, J. (2020) Role of Human Mesenchymal Stem Cells in Regenerative Therapy. Cells, 10, Article No. 54.
https://doi.org/10.3390/cells10010054
|
[59]
|
Moriscot, C., de Fraipont, F., Richard, M.J., Marchand, M., Savatier, P., Bosco, D., Favrot, M. and Benhamou, P.Y. (2005) Human Bone Marrow Mesenchymal Stem Cells Can Express In-sulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvi-ronmental Manipulation in Vitro. Stem Cells, 23, 594-603. https://doi.org/10.1634/stemcells.2004-0123
|
[60]
|
Krampera, M., Pasini, A., Pizzolo, G., Cosmi, L., Romagnani, S. and Annunziato, F. (2006) Regenerative and Immunomodulatory Potential of Mesenchymal Stem Cells. Current Opinion in Pharmacology, 6, 435-441.
https://doi.org/10.1016/j.coph.2006.02.008
|
[61]
|
Mishra, V.K., Shih, H.H., Parveen, F., Lenzen, D., Ito, E., Chan, T.F. and Ke, L.Y. (2020) Identifying the Therapeutic Significance of Mesenchymal Stem Cells. Cells, 9, Article No. 1145. https://doi.org/10.3390/cells9051145
|
[62]
|
Wu, X.H., Liu, C.P., Xu, K.F., Mao, X.D., Zhu, J., Jiang, J.J., Cui, D., Zhang, M., Xu ,Y. and Liu, C. (2007) Reversal of Hyperglycemia in Diabetic Rats by Portal Vein Transplantation of Is-let-Like Cells Generated from Bone Marrow Mesenchymal Stem Cells. World Journal of Gastroenterology, 13, 3342-3349.
https://doi.org/10.3748/wjg.v13.i24.3342
|
[63]
|
Xin, Y., Jiang, X., Wang, Y., Su, X., Sun, M., Zhang, L., Tan, Y., Wintergerst, K.A., Li, Y. and Li, Y. (2016) Insulin-Producing Cells Differentiated from Human Bone Marrow Mesen-chymal Stem Cells in Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia. PLoS ONE, 11, Article ID: e0145838.
https://doi.org/10.1371/journal.pone.0145838
|
[64]
|
Wu, L.F., Wang, N.N., Liu, Y.S. and Wei, X. (2009) Differen-tiation of Wharton’s Jelly Primitive Stromal Cells into Insulin-Producing Cells in Comparison with Bone Marrow Mes-enchymal Stem Cells. Tissue Engineering Part A, 15, 2865-2873. https://doi.org/10.1089/ten.tea.2008.0579
|
[65]
|
Si, Y., Zhao, Y., Hao, H., Liu, J., Guo, Y., Mu, Y., Shen, J., Cheng, Y., Fu, X. and Han, W. (2012) Infusion of Mesen-chymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving In-sulin Sensitivity. Diabetes, 61, 1616-1625. https://doi.org/10.2337/db11-1141
|
[66]
|
Hao, H., Liu, J., Shen, J., Zhao, Y., Liu, H., Hou, Q., Tong, C., Ti, D., Dong, L., Cheng, Y., Mu, Y., Liu, J., Fu, X. and Han, W. (2013) Multiple Intra-venous Infusions of Bone Marrow Mesenchymal Stem Cells Reverse Hyperglycemia in Experimental Type 2 Diabetes Rats. Biochemical and Biophysical Research Communications, 436, 418-423.
https://doi.org/10.1016/j.bbrc.2013.05.117
|
[67]
|
Dazzi, F. and Horwood, N.J. (2007) Potential of Mesenchymal Stem Cell Therapy. Current Opinion in Oncology, 19, 650-655. https://doi.org/10.1097/CCO.0b013e3282f0e116
|
[68]
|
De Miguel, M.P., Fuentes-Julián, S., Blázquez-Martínez, A., Pascual, C.Y., Aller, M.A., Arias, J. and Arnalich-Montiel, F. (2012) Immunosuppressive Properties of Mesenchymal Stem Cells: Advances and Applications. Current Molecular Medicine, 12, 574-591. https://doi.org/10.2174/156652412800619950
|
[69]
|
Selmani, Z., Naji, A., Zidi, I., Favier, B., Gaiffe, E., Obert, L., Borg, C., Saas, P., Tiberghien, P., Rouas-Freiss, N., Carosella, E.D. and Deschaseaux, F. (2008) Human Leukocyte An-tigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Func-tion and to Induce CD4+CD25highFOXP3+ Regulatory T Cells. Stem Cells, 26, 212-222. https://doi.org/10.1634/stemcells.2007-0554
|
[70]
|
Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cappiello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G.L., Pistoia, V. and Uccelli, A. (2006) Human Mesenchymal Stem Cells Modulate B-Cell Functions. Blood, 107, 367-372. https://doi.org/10.1182/blood-2005-07-2657
|
[71]
|
Cho, J., D’Antuono, M., Glicksman, M., Wang, J. and Jonklaas, J. (2018) A Review of Clinical Trials: Mesenchymal Stem Cell Transplant Therapy in Type 1 and Type 2 Diabetes Mellitus. American Journal of Stem Cells, 7, 82-93.
|
[72]
|
Tritschler, S., Theis, F.J., Lickert, H. and Böttcher, A. (2017) Systematic Single-Cell Analysis Provides New Insights into Hetero-geneity and Plasticity of the Pancreas. Molecular Metabolism, 6, 974-990.
https://doi.org/10.1016/j.molmet.2017.06.021
|
[73]
|
Fujitani, Y. (2017) Transcriptional Regulation of Pancreas De-velopment and β-Cell Function [Review]. Endocrine Journal, 64, 477-486. https://doi.org/10.1507/endocrj.EJ17-0098
|
[74]
|
Peshavaria, M., Larmie, B.L., Lausier, J., Satish, B., Habibovic, A., Roskens, V., Larock, K., Everill, B., Leahy, J.L. and Jetton, T.L. (2006) Regulation of Pancreatic Beta-Cell Regeneration in the Normoglycemic 60% Partial-Pancrea- tectomy Mouse. Diabetes, 55, 3289-3298. https://doi.org/10.2337/db06-0017
|
[75]
|
Bock, T. (2004) The Source(s) for New Pancreatic Beta Cells in Adult Life. BioEssays, 26, 1156-1159.
https://doi.org/10.1002/bies.20143
|
[76]
|
Kopp, J.L., Dubois, C.L., Hao, E., Thorel, F., Herrera, P.L. and Sander, M. (2011) Progenitor Cell Domains in the Developing and Adult Pancreas. Cell Cycle, 10, 1921-1927. https://doi.org/10.4161/cc.10.12.16010
|
[77]
|
Sharon, N., Chawla, R., Mueller, J., Vanderhooft, J., Whitehorn, L.J., Rosenthal, B., Gürtler, M., Estanboulieh, R.R., Shvartsman, D., Gifford, D.K., Trapnell, C. and Melton, D. (2019) A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell, 176, 790-804.e13.
https://doi.org/10.1016/j.cell.2018.12.003
|
[78]
|
Lysy, P.A., Weir, G.C. and Bonner-Weir, S. (2012) Concise Re-view: Pancreas Regeneration: Recent Advances and Perspectives. Stem Cells Translational Medicine, 1, 150-159. https://doi.org/10.5966/sctm.2011-0025
|
[79]
|
Bonner-Weir, S., Inada, A., Yatoh, S., Li, W.C., Aye, T., Toschi, E. and Sharma, A. (2008) Transdifferentiation of Pancreatic Ductal Cells to Endocrine Beta-Cells. Biochemical Society Transactions, 36, 353-356.
https://doi.org/10.1042/BST0360353
|
[80]
|
Wang, Y., Lanzoni, G., Carpino, G., Cui, C.B., Dominguez-Bendala, J., Wauthier, E., Cardinale, V., Oikawa, T., Pileggi, A., Gerber, D., Furth, M.E., Alvaro, D., Gaudio, E., Inverardi, L. and Reid, L.M. (2013) Biliary Tree Stem Cells, Precursors to Pancreatic Committed Progenitors: Evidence for Possible Life-Long Pancreatic Organogenesis. Stem Cells, 31, 1966-1979. https://doi.org/10.1002/stem.1460
|
[81]
|
Katdare, M.R., Bhonde, R.R. and Parab, P.B. (2004) Analysis of Morphological and Functional Maturation of Neoislets Gener-ated in Vitro from Pancreatic Ductal Cells and Their Suitability for Islet Banking and Transplantation. Journal of Endo-crinology, 182, 105-112. https://doi.org/10.1677/joe.0.1820105
|
[82]
|
Hao, E., Tyrberg, B., Itkin-Ansari, P., Lakey, J.R., Geron, I., Monosov, E.Z., Barcova, M., Mercola, M., and Levine, F. (2006) Beta-Cell Differentiation from Nonen-docrine Epithelial Cells of the Adult Human Pancreas. Nature Medicine, 12, 310-316. https://doi.org/10.1038/nm1367
|
[83]
|
Lendahl, U., Zimmerman, L.B. and McKay, R.D. (1990) CNS Stem Cells Express a New Class of Intermediate Filament Protein. Cell, 60, 585-595. https://doi.org/10.1016/0092-8674(90)90662-X
|
[84]
|
Wiese, C., Rolletschek, A., Kania, G., Blyszczuk, P., Tarasov, K.V., Tarasova, Y., Wersto, R.P., Boheler, K.R. and Wobus, A.M. (2004) Nestin Expression—A Property of Mul-ti-Lineage Progenitor Cells? Cellular and Molecular Life Sciences CMLS, 61, 2510-2522. https://doi.org/10.1007/s00018-004-4144-6
|
[85]
|
Bernal, A. and Arranz, L. (2018) Nestin-Expressing Progenitor Cells: Function, Identity and Therapeutic Implications. Cellular and Molecular Life Sciences, 75, 2177-2195. https://doi.org/10.1007/s00018-018-2794-z
|
[86]
|
Scharenberg, C.W., Harkey, M.A. and Torok-Storb, B. (2002) The ABCG2 Transporter Is an Efficient Hoechst 33342 Efflux Pump and Is Preferentially Expressed by Immature Hu-man Hematopoietic Progenitors. Blood, 99, 507-512.
https://doi.org/10.1182/blood.V99.2.507
|
[87]
|
Sapir, T., Shternhall, K., Meivar-Levy, I, Blumenfeld, T., Cohen, H., Skutelsky, E, Eventov-Friedman, S., Barshack, I., Goldberg, I., Pri-Chen, S., Ben-Dor, L., Polak-Charcon, S., Karasik, A., Shimon, I., Mor, E. and Ferber, S. (2005) Cell-Replacement Therapy for Diabetes: Generating Functional Insu-lin-Producing Tissue from Adult Human Liver Cells. Proceedings of the National Academy of Sciences of the United States of America, 102, 7964-7969.
https://doi.org/10.1073/pnas.0405277102
|
[88]
|
Shternhall-Ron, K., Quintana, F.J., Perl, S., Meivar-Levy, I., Bar-shack, I., Cohen, I.R. and Ferber, S. (2007) Ectopic PDX-1 Expression in Liver Ameliorates Type 1 Diabetes. Journal of Autoimmunity, 28, 134-142.
https://doi.org/10.1016/j.jaut.2007.02.010
|
[89]
|
Lee, Y.N., Yi, H.J., Seo, E.H., Oh, J., Lee, S., Ferber, S., Okano, T., Shim, I.K. and Kim, S.C. (2021) Improvement of the Therapeutic Capacity of Insulin-Producing Cells Trans-Differentiated from Human Liver Cells Using Engineered Cell Sheet. Stem Cell Research & Therapy, 12, Article No. 3. https://doi.org/10.1186/s13287-020-02080-0
|
[90]
|
Wild, S.L. and Tosh, D. (2021) Molecular Mechanisms of Transcription Factor Mediated Cell Reprogramming: Conversion of Liver to Pancreas. Biochemical Society Transac-tions, 49, 579-590. https://doi.org/10.1042/BST20200219
|
[91]
|
Herrera, M.B., Bruno, S., Buttiglieri, S., Tetta, C., Gatti, S., Deregibus, M.C., Bussolati, B. and Camussi, G. (2006) Isolation and Characterization of a Stem Cell Popula-tion from Adult Human Liver. Stem Cells, 24, 2840-2850.
https://doi.org/10.1634/stemcells.2006-0114
|
[92]
|
Ahmed, E.M. (2015) Hydrogel: Preparation, Characterization, and Applications: A Review. Journal of Advanced Research, 6, 105-121. https://doi.org/10.1016/j.jare.2013.07.006
|
[93]
|
Knobeloch, T., Abadi, S.E.M., Bruns, J., Zustiak, S.P. and Kwon, G. (2017) Injectable Polyethylene Glycol Hydrogel for Islet Encapsulation: An in Vitro and in Vivo Characterization. Bi-omedical Physics & Engineering Express, 3, Article ID: 035022. https://doi.org/10.1088/2057-1976/aa742b
|
[94]
|
Zhi, Z.L., Khan, F. and Pickup, J.C. (2013) Multilayer Nanoen-capsulation: A Nanomedicine Technology for Diabetes Research and Management. Diabetes Research and Clinical Practice, 100, 162-169.
https://doi.org/10.1016/j.diabres.2012.11.027
|
[95]
|
Kozlovskaya, V., Zavgorodnya, O., Chen, Y., Ellis, K., Tse, H.M., Cui, W., Thompson, J.A. and Kharlampieva, E. (2012) Ultrathin Polymeric Coatings Based on Hydrogen-Bonded Polyphenol for Protection of Pancreatic Islet Cells. Advanced Functional Materials, 22, 3389-3398. https://doi.org/10.1002/adfm.201200138
|
[96]
|
Syed, F., Bugliani, M., Novelli, M., Olimpico, F., Suleiman, M., Marselli, L., Boggi, U., Filipponi, F., Raffa, V., Krol, S., Campani, D., Masiello, P., De Tata, V. and Marchetti, P. (2018) Conformal Coating by Multilayer Nano-Encapsulation for the Protection of Human Pancreatic Islets: In-Vitro and in-Vivo Studies. Nanomedicine, 14, 2191-2203.
https://doi.org/10.1016/j.nano.2018.06.013
|
[97]
|
Krol, S., del Guerra, S., Grupillo, M., Diaspro, A., Gliozzi, A. and Marchetti, P. (2006) Multilayer Nanoencapsulation. New Approach for Immune Protection of Human Pancreatic Islets. Nano Letters, 6, 1933-1939.
https://doi.org/10.1021/nl061049r
|
[98]
|
Pickup, J.C., Zhi, Z.L., Khan, F., Saxl, T. and Birch, D.J. (2008) Nano-medicine and Its Potential in Diabetes Research and Practice. Diabetes/Metabolism Research and Reviews, 24, 604-610. https://doi.org/10.1002/dmrr.893
|
[99]
|
Miura, S., Teramura, Y. and Iwata, H. (2006) Encapsulation of Islets with Ultra-Thin Polyion Complex Membrane through Poly(Ethylene Glycol)-Phospholipids Anchored to Cell Membrane. Biomaterials, 27, 5828-5835.
https://doi.org/10.1016/j.biomaterials.2006.07.039
|
[100]
|
Pérez-Luna, V.H. and González-Reynoso, O. (2018) En-capsulation of Biological Agents in Hydrogels for Therapeutic Applications. Gels, 4, Article No. 61. https://doi.org/10.3390/gels4030061
|
[101]
|
Vaithilingam, V. and Tuch, B.E. (2011) Islet Transplantation and En-capsulation: An Update on Recent Developments. The Review of Diabetic Studies, 8, 51-67. https://doi.org/10.1900/RDS.2011.8.51
|
[102]
|
Omami, M., McGarrigle, J.J., Reedy, M., Isa, D., Ghani, S., Mar-chese, E., Bochenek, M.A., Longi, M., Xing, Y., Joshi, I., Wang, Y. and Oberholzer, J. (2017) Islet Microencapsulation: Strategies and Clinical Status in Diabetes. Current Diabetes Reports, 17, Article No. 47. https://doi.org/10.1007/s11892-017-0877-0
|
[103]
|
Shimoda, M. and Matsumoto, S. (2017) Microencapsulation in Clinical Islet Xenotransplantation. In: Opara, E., Ed., Cell Microencapsulation, Vol. 1479, Humana Press, New York, 335-345.
https://doi.org/10.1007/978-1-4939-6364-5_25
|
[104]
|
de Vos, P., Faas, M.M., Strand, B. and Calafiore, R. (2006) Alginate-Based Microcapsules for Immunoisolation of Pancreatic Islets. Biomaterials, 27, 5603-5617. https://doi.org/10.1016/j.biomaterials.2006.07.010
|
[105]
|
Gungor-Ozkerim, P.S., Inci, I., Zhang, Y.S., Khademhos-seini, A. and Dokmeci, M.R. (2018) Bioinks for 3D Bioprinting: An Overview. Biomaterials Science, 6, 915-946. https://doi.org/10.1039/C7BM00765E
|
[106]
|
Rider, P., Kačarević, Ž.P., Alkildani, S., Retnasingh, S. and Barbeck, M. (2018) Bioprinting of tissue engineering scaffolds. Journal of Tissue Engineering, 9, Article ID: 2041731418802090.
https://doi.org/10.1177/2041731418802090
|
[107]
|
Boyd-Moss, M., Fox, K., Brandt, M., Nisbet, D. and Williams, R. (2017) Bioprinting and Biofabrication with Peptide and Protein Biomaterials. In: Sunna, A., Care, A. and Bergquist, P., Eds., Peptides and Peptide-Based Biomaterials and Their Biomedical Applications, Vol. 1030, Springer, Cham, 95-129. https://doi.org/10.1007/978-3-319-66095-0_5
|
[108]
|
Kim, J., Kang, K., Drogemuller, C.J., Wallace, G.G. and Coates, P.T. (2019) Bioprinting an Artificial Pancreas for Type 1 Diabetes. Current Diabetes Reports, 19, Article No. 53. https://doi.org/10.1007/s11892-019-1166-x
|
[109]
|
Liu, X., Carter, S.D., Renes, M.J., Kim, J., Rojas-Canales, D.M., Penko, D., Angus, C., Beirne, S., Drogemuller, C.J., Yue, Z., Coates, P.T. and Wallace, G.G. (2019) Development of a Coaxial 3D Printing Platform for Biofabrication of Implantable Islet-Containing Constructs. Advanced Healthcare Mate-rials, 8, Article ID: 1801181.
https://doi.org/10.1002/adhm.201801181
|
[110]
|
Duin, S., Schütz, K., Ahlfeld, T., Lehmann, S., Lode, A., Ludwig, B. and Gelinsky, M. (2019) 3D Bioprinting of Functional Islets of Langerhans in an Alginate/Methylcellulose Hydrogel Blend. Advanced Healthcare Materials, 8, Article ID: 1801631. https://doi.org/10.1002/adhm.201801631
|
[111]
|
Song, S. and Roy, S. (2016) Progress and Challenges in Macroen-capsulation Approaches for Type 1 Diabetes (T1D) Treatment: Cells, Biomaterials, and Devices. Biotechnology and Bio-engineering, 113, 1381-1402.
https://doi.org/10.1002/bit.25895
|
[112]
|
Goswami, D., Domingo-Lopez, D.A., Ward, N.A., Millman, J.R., Duffy, G.P., Dolan, E.B. and Roche, E.T. (2021) Design Considerations for Macroencapsulation Devices for Stem Cell Derived Islets for the Treatment of Type 1 Diabetes. Advanced Science, 8, Article ID: 2100820. https://doi.org/10.1002/advs.202100820
|
[113]
|
Skrzypek, K., Groot Nibbelink, M., Liefers-Visser, J., Smink, A.M., Stoimenou, E., Engelse, M.A., de Koning, E.J.P., Karperien, M., de Vos, P., van Apeldoorn, A. and Stamatialis, D. (2020) A High Cell-Bearing Capacity Multibore Hollow Fiber Device for Macroencapsulation of Islets of Langerhans. Macromolecular Bioscience, 20, Article ID: 2000021.
https://doi.org/10.1002/mabi.202000021
|
[114]
|
Barkai, U., Rotem, A. and de Vos, P. (2016) Survival of Encapsu-lated Islets: More than a Membrane Story. World Journal of Transplantation, 6, 69-90. https://doi.org/10.5500/wjt.v6.i1.69
|
[115]
|
Ludwig, B., Reichel, A., Steffen, A., Zimerman, B., Schally, A.V., Block, N.L., Colton, C.K., Ludwig, S., Kersting, S., Bonifacio, E., Solimena, M., Gendler, Z., Rotem, A., Barkai, U. and Born-stein, S.R. (2013) Transplantation of Human Islets without Immunosuppression. Proceedings of the National Academy of Sciences of the United States of America, 110, 19054-19058. https://doi.org/10.1073/pnas.1317561110
|
[116]
|
Gholipourmalekabadi, M., Zhao, S., Harrison, B.S., Mozafari, M. and Seifalian, A.M. (2016) Oxygen-Generating Biomaterials: A New, Viable Paradigm for Tissue Engineering? Trends in Biotechnology, 34, 1010-1021.
https://doi.org/10.1016/j.tibtech.2016.05.012
|
[117]
|
Bertuzzi, F., Marzorati, S. and Secchi, A. (2006) Islet Cell Transplantation. Current Molecular Medicine, 6, 369-374.
https://doi.org/10.2174/156652406777435453
|
[118]
|
Ryan, E.A., Paty, B.W., Senior, P.A. and Shapiro, A.M. (2004) Risks and Side Effects of Islet Transplantation. Current Diabetes Reports, 4, 304-309. https://doi.org/10.1007/s11892-004-0083-8
|
[119]
|
Katta, S., Desimone, M.E. and Weinstock, R.S. (2021) Pancreatic Islet Function Tests. In: Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Grossman, A., Hershman, J.M., Hofland, J., Kalra, S., Kaltsas, G., Koch, C., Kopp, P., Korbonits, M., Kovacs, C.S., Kuohung, W., Laferrère, B., McGee, E.A., McLachlan, R., Morley, J.E., New, M., Purnell, J., Sahay, R., Singer, F., Stratakis, C.A., Trence, D.L., Wilson, D.P., Eds., Endotext. MDText.com, Inc.; South Dartmouth, MA.
|
[120]
|
Taylor, C.J., Peacock, S., Chaudhry, A.N., Bradley, J.A. and Bolton, E.M. (2012) Generating an iPSCs Bank for HLA-Matched Tis-sue Transplantation Based on Known Donor and Recipient HLA Types. Cell Stem Cell, 11, 147-152.
https://doi.org/10.1016/j.stem.2012.07.014
|
[121]
|
Taylor, C.J., Bolton, E.M. and Bradley, J.A. (2011) Immunologi-cal Considerations for Embryonic and Induced Pluripotent Stem Cell Banking. Philosophical Transactions of the Royal Society B: Biological Sciences, 366, 2312-2322.
https://doi.org/10.1098/rstb.2011.0030
|
[122]
|
Morishima, Y., Azuma, F., Kashiwase, K., Matsumoto, K., Orihara, T., Yabe, H., Kato, S., Kato, K., Kai, S., Mori, T., Nakajima, K., Morishima, S., Satake, M., Takanashi, M. and Yabe, T. (2018) Japanese Cord Blood Transplantation Histocompatibility Research Group. Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation. Stem Cells Transla-tional Medicine, 7, 173-179.
https://doi.org/10.1002/sctm.17-0169
|
[123]
|
Marek-Trzonkowska, N., Mysliwiec, M., Dobyszuk, A., Grabowska, M., Techmanska, I., Juscinska, J., Wujtewicz, M.A., Witkowski, P., Mlynarski, W., Balcerska, A., Mysliwska, J. and Trzonkowski, P. (2012) Administration of CD4+CD25highCD127−Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children. Diabetes Care, 35, 1817-1820. https://doi.org/10.2337/dc12-0038
|
[124]
|
Ma-rek-Trzonkowska, N., Myśliwiec, M., Dobyszuk, A., Grabowska, M., Derkowska, I., Juścińska, J., Owczuk, R., Szadkowska, A., Witkowski, P., Młynarski, W., Jarosz-Chobot, P., Bossowski, A., Siebert, J. and Trzonkowski, P. (2014) Therapy of Type 1 Diabetes with CD4+CD25highCD127-Regulatory T Cells Prolongs Survival of Pancreatic Is-lets—Results of One Year Follow-Up. Clinical Immunology, 153, 23-30. https://doi.org/10.1016/j.clim.2014.03.016
|
[125]
|
Longoni, B., Szilagyi, E., Quaranta, P., Paoli, G.T., Tripodi, S., Urbani, S., Mazzanti, B., Rossi, B., Fanci, R., Demontis, G.C., Marzola, P., Saccardi, R., Cintorino, M. and Mosca, F. (2010) Mesenchymal Stem Cells Prevent Acute Rejection and Prolong Graft Function in Pancreatic Islet Transplantation. Diabetes Technology & Therapeutics, 12, 435-446.
https://doi.org/10.1089/dia.2009.0154
|
[126]
|
Berman, D.M., Willman, M.A., Han, D., Kleiner, G., Kenyon, N.M., Cabrera, O., Karl, J.A., Wiseman, R.W., O’Connor, D.H., Bartholomew, A.M. and Kenyon, N.S. (2010) Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates. Diabetes, 59, 2558-2568. https://doi.org/10.2337/db10-0136
|
[127]
|
Hematti, P., Kim, J., Stein, A.P. and Kaufman, D. (2013) Potential Role of Mesenchymal Stromal Cells in Pancreatic Islet Transplantation. Transplantation Reviews, 27, 21-29. https://doi.org/10.1016/j.trre.2012.11.003
|
[128]
|
Reading, J.L., Sabbah, S., Busch, S. and Tree. T.I. (2013) Mesen-chymal Stromal Cells as a Means of Controlling Pathological T-Cell Responses in Allogeneic Islet Transplantation. Cur-rent Opinion in Organ Transplantation, 18, 59-64.
https://doi.org/10.1097/MOT.0b013e32835c2adf
|
[129]
|
Xu, D.M., Yu, X.F., Zhang, D., Zhang, M.X., Zhou, J.F., Tan, P.H. and Ding, Y.C. (2012) Mesenchymal Stem Cells Differentially Mediate Regulatory T Cells and Conventional Effector T Cells to Protect Fully Allogeneic Islet Grafts in Mice. Diabetologia, 55, 1091-1102. https://doi.org/10.1007/s00125-011-2433-9
|
[130]
|
Duffy, M.M., Ritter, T., Ceredig, R. and Griffin, M.D. (2011) Mesenchymal Stem Cell Effects on T-Cell Effector Pathways. Stem Cell Research & Therapy, 2, 34. https://doi.org/10.1186/scrt75
|
[131]
|
Mandal, P.K., Ferreira, L.M., Collins, R., Meissner, T.B., Boutwell, C.L., Friesen, M., Vrbanac, V., Garrison, B.S., Stortchevoi, A., Bryder, D., Musunuru, K., Brand, H., Tager, A.M., Allen, T.M., Talkowski, M.E., Rossi, D.J. and Cowan, C.A. (2014) Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells Using CRISPR/ Cas9. Cell Stem Cell, 15, 643-652. https://doi.org/10.1016/j.stem.2014.10.004
|
[132]
|
Ye, Q., Sung, T.C., Yang, J.M., Ling, Q.D., He, Y. and Higuchi, A. (2020) Generation of Universal and Hypoimmunogenic Human Pluripotent Stem Cells. Cell Proliferation, 53, Article No. e12946. https://doi.org/10.1111/cpr.12946
|
[133]
|
Wang, W., Xu, S., Ren, Z., Jiang, J. and Zheng, S. (2015) Gut Microbiota and Allogeneic Transplantation. Journal of Translational Medicine, 13, Article No. 275. https://doi.org/10.1186/s12967-015-0640-8
|
[134]
|
Saleem, M., Sabir, S., Akhtar, M.F., Zahid, S., Niazi, S.G., Naeem, M., Saleem, U. and Saleem, A. (2019) Stem Cell Therapy for Diabetes Mellitus: Recent Progress and Hurdles. Critical Reviews™ in Eukaryotic Gene Expression, 29, 471-482. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2019025723
|
[135]
|
Hwang, G., Jeong, H., Yang, H.K., Kim, H.S., Hong, H., Kim, N.J., Oh, I.H. and Yim, H.W. (2019) Efficacies of Stem Cell Therapies for Functional Improve-ment of the β Cell in Patients with Diabetes: A Systematic Review of Controlled Clinical Trials. International Journal of Stem Cells, 12, 195-205. https://doi.org/10.15283/ijsc18076
|
[136]
|
Chen, S., Du, K. and Zou, C. (2020) Current Progress in Stem Cell Therapy for Type 1 Diabetes Mellitus. Stem Cell Research & Therapy, 11, Article No. 275. https://doi.org/10.1186/s13287-020-01793-6
|
[137]
|
Volarevic, V., Markovic, B.S., Gazdic, M., Volarevic, A., Jovi-cic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M. and Stojkovic, M. (2018) Ethical and Safety Issues of Stem Cell-Based Therapy. International Journal of Medical Sciences, 15, 36-45. https://doi.org/10.7150/ijms.21666
|
[138]
|
Chan, S. and Harris, J. (2008) Adam’s Fibroblast? The (Pluri)Potential of IPCs. Journal of Medical Ethics, 34, 64-66.
https://doi.org/10.1136/jme.2007.023937
|
[139]
|
Romano, G. (2008) Artificial Reprogramming of Human Somatic Cells to Generate Pluripotent Stem Cells: A Possible Alternative to the Controversial Use of Human Embryonic Stem Cells. Drug News & Perspectives, 21, 440-445.
|
[140]
|
Zweigerdt, R. (2009) Large Scale Production of Stem Cells and Their Derivatives. In: Martin, U., Ed., Engineering of Stem Cells, Vol. 114, Springer, Berlin, Heidelberg, 201-235. https://doi.org/10.1007/10_2008_27
|
[141]
|
Tavassoli, H., Alhosseini, S.N., Tay, A., Chan, P.P.Y., Weng, Oh.S.K. and Warkiani, M.E. (2018) Large-Scale Production of Stem Cells Utilizing Microcarriers: A Biomaterials Engineering Perspective from Academic Research to Commercialized Products. Biomaterials, 181, 333-346. https://doi.org/10.1016/j.biomaterials.2018.07.016
|